EOF.AU · Ecofibre Limited

-

Please sign in to comment on EOF.AU

1 Comment

Admin

4 years, 1 month ago

Ecofibre Limited is currently in a long term downtrend where the price is trading 43.3% below its 200 day moving average.

From a valuation standpoint, the stock is 96.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.2.

Ecofibre Limited's total revenue sank by 49.5% to $15M since the same quarter in the previous year.

Its net income has dropped by 178.4% to $-6M since the same quarter in the previous year.

Finally, its free cash flow fell by 4.4% to $-5M since the same quarter in the previous year.

Based on the above factors, Ecofibre Limited gets an overall score of 1/5.

ISIN	AU0000040057
Exchange	AU
CurrencyCode	AUD
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Market Cap	8M
PE Ratio	None
Target Price	1.9
Beta	1.06
Dividend Yield	None

ABOUT

Ecofibre Limited

Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer textiles, and hemp related food products. Further, it is involved in patient-centered cannabinoid-based drug activities. Ecofibre Limited was incorporated in 2009 and is based in Sydney, Australia.

EOF.AU · Ecofibre Limited

-

Ecofibre Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Ecofibre Limited using a moving average strategy